Accuracy and Safety of Endobronchial Ultrasound (EBUS) in Suspected Non-malignant Mediastinal Lymphadenopathy

NCT ID: NCT02398864

Last Updated: 2015-03-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-03-31

Study Completion Date

2017-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To examine whether EBUS with transbronchial needle aspiration (TBNA) can accurately and safely diagnose enlarged lymph nodes in the chest in patients without suspected malignancy

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There is no single method to investigate mediastinal LN invasion. Hence, a patient may have to undergo several tests and procedures. Noninvasive and invasive approaches are employed. Within the invasive techniques, endoscopic ultrasonography with needle aspiration (EUS-FNA) and endobronchial ultrasonography with transbronchial needle aspiration (EBUS-TBNA) are gaining importance in mediastinal staging. Endobronchial Ultrasound (EBUS) is a procedure that is performed via flexible bronchoscopy under moderate sedation for visualization of lymph nodes in the chest and biopsy under real-time guidance usually for the staging of lung cancer or evaluation of enlarged lymph nodes. In addition, lung lesions or masses can be visualized and biopsied in the same sitting. The use of EBUS has enhanced the safety and diagnostic yield of flexible bronchoscopy. It provides ultrasonographic images and permits needle aspiration under direct vision for cytology specimen analysis. As more evidence is being accumulated on these staging approaches, the number of cervical mediastinoscopies, considered as the gold-standard for mediastinal staging, is diminishing.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mediastinal Lymphadenopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

endobronchial ultrasound bronchoscopy

EBUS with TBNA

Group Type EXPERIMENTAL

EBUS with TBNA

Intervention Type PROCEDURE

endobronchial ultrasound (EBUS) with transbronchial needle aspiration (TBNA)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EBUS with TBNA

endobronchial ultrasound (EBUS) with transbronchial needle aspiration (TBNA)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adults (18 Years and older) with mediastinal lymphadenopathy.

Exclusion Criteria

* known or suspected malignancy
* no informed consent
* pts with anterior mediastinal lesions
* contraindications to EBUS
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hannover Medical School

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas Fuehner, MD

Role: PRINCIPAL_INVESTIGATOR

Hannover Medical School

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Thomas Fuehner, MD

Role: CONTACT

+49 511 532 ext. 2699

Jens Gottlieb, MD

Role: CONTACT

+49 511 532 ext. 4681

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1203-2015

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

EBUS-TBNA vs Acquire TBNB
NCT04200105 UNKNOWN NA
EBUS/Spectrum Analysis
NCT01972386 COMPLETED
EBUS-TBNA Versus EBUS-TBNB
NCT01467635 WITHDRAWN NA
EBUS-TBNA vs Flex 19G EBUS-TBNA
NCT02592837 COMPLETED NA